|
National Stock Number(NSN): 6505-01-285-6412 (6505012856412, 012856412)
| NIIN: |
01-285-6412 |
Item Name: |
BROMPHENIRAMINE MALEATE,PHENYLEPHRINE HYDROCHLORIDE,AND PHENYLTOLOXAMINE CITRATE CAPSULES |
INC: |
41132
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
41132 |
| ISC: |
2 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Mar-01-1994 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
8-0523 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ATROHIST SPRINKLE |
48357
|
CELLTECH PHARMACEUTICALS, INC. |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC53014-0022-10 |
48357
|
CELLTECH PHARMACEUTICALS, INC. |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC53014-0022-17 |
48357
|
CELLTECH PHARMACEUTICALS, INC. |
H |
5 |
9 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
|
1 |
|
$33.05 |
BT |
|
C2201X- |
|
H |
| DN |
JDC |
L |
|
M |
|
1 |
|
$33.05 |
BT |
|
9L----- |
|
H |
| DS |
JDC |
L |
|
M |
|
1 |
|
$33.05 |
BT |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
100 EA |
|
|
|
|
| DN |
K |
100 EA |
|
|
|
|
| DS |
K |
100 EA |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 MILLIGRAMS BROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS PHENYLTOLOXAMINE CITRATE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| AKJF |
LONG ACTION METHOD |
EXTENDED RELEASE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
40.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
2.70 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
216 |
| FEAT |
SPECIAL FEATURES |
DYE-FREE SUSTAINED-RELEASE BEADS W/1 EACH OVERSIZED CAPSULE WILL HAVE A SUSTAINED DURATION OF ACTION F/12 HRS,RELEASING THE FOLLOWING PERCENTAGE OF EACH DRUG OVER ELAPSED TIME:15-30% IN 1 HR;50-75% PCT IN 4 HRS;NOT LESS THAN 85% IN 8 HRS |
| PKQT |
INTERMEDIATE PACKAGE QUANTITY |
12 |
| SUCB |
UNIT OF ISSUE CUBE |
0.01 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.18 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
Z |
|
|
|
|
| FSKX |
|
|
3 |
Z |
|
|
|
|
| N9LM |
|
|
3 |
Z |
|
|
|
|
|